NASDAQ:VIR

Vir Biotechnology Stock Predictions

etoro logo Buy VIR
*Your capital is at risk
$8.77
+0.0300 (+0.343%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VIR Prediction Chart

VIR Predictions History

Latest community submissions for VIR.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 11, 2026 $9.59 -2.89% $9.82 V 97.70% 1
Mar 11, 2026 $9.70 -1.81% $9.82 V 98.79% 2
May 22, 2025 $4.65 +3.18% $4.61 V 99.06% 2
May 22, 2025 $4.60 +1.99% $4.61 V 99.77% 6
May 22, 2025 Bullish $4.61 X 1
Jan 17, 2025 $10.44 +3.86% $10.11 V 96.75% 1
Jan 17, 2025 $10.29 +2.42% $10.11 V 98.19% 1
Jan 17, 2025 $13.15 +30.85% $10.11 V 69.93% 1
Sep 26, 2023 $9.40 +2.08% $9.25 V 98.36% 1
Sep 26, 2023 $9.33 +1.30% $9.25 V 99.14% 3
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VIR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIR BIOTECHNOLOGY, INC.
Vir Biotechnology
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus....
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE